Registered entities
Oribiotech Ltd
Reg. No. 9757696United Kingdom
Innovation
39 patent families (24 granted) — focus: Chemistry & metallurgy, Operations & transport, Human necessities; filing pace steady. Cited 1,085 times.
| Year | Filings |
|---|---|
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 12 |
| 2021 | 12 |
| 2022 | 18 |
| 2023 | 22 |
| 2024 | 20 |
| 2025 | 26 |
| 2026 | 7 |
Social engagement
Social engagement: 19.5K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
19 investors on record; lead investors include Amadeus Capital, Delin Ventures, Kindred Capital, Novalis LifeSciences.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 37% |
| Private equity | 1 | 5% |
| Other / undisclosed | 11 | 58% |
Recent activity
2 Jul 2026
Partnership
ImmuXell Biotech
25 Jun 2026
Event
CAR-T Manufacturing Webinar with BlueWhale Bio on Cell-derived nanoparticle (CDNP)-based activation paired with IRO®
23 Jun 2026
Product launch
IRO®